Skip to main content
Top
Published in: Child's Nervous System 5/2010

01-05-2010 | Brief Communication

Use of intrathecal urokinase in repeated shunt and external ventricular drain blockage from high CSF protein due to an optic pathway glioma

Authors: David Shooman, Girish V. Vajramani, Jennifer Davidson, Owen C. Sparrow

Published in: Child's Nervous System | Issue 5/2010

Login to get access

Abstract

Introduction

High cerebrospinal fluid (CSF) protein is a recognised association of optic pathway gliomas. This can occlude ventriculoperitoneal (VP) shunt catheters or external ventricular drains (EVD).

Case report

We describe an 8-year-old boy with an optic pathway glioma, who had frequent episodes of a blocked VP shunt and EVD due to high CSF protein level. This responded favourably to repeated urokinase instillation into the catheter lumen. We present the course of treatment and the method of administration and review the literature behind thrombolytic therapy for occluded catheter devices.

Conclusion

Intrathecal urokinase was effective in unblocking the EVD and lysing the protein clots within the ventricle. We found no previously published cases of intrathecal urokinase for this problem. This novel intervention seemed promising as a safe and effective means of maintaining EVD patency in cases complicated by excessive protein loads in CSF and hydrocephalus.
Literature
1.
go back to reference Anderson M, Matthews KB, Stuart J (1978) Coagulation and fibrinolytic activity of cerebrospinal fluid. J Clin Pathol 31:488–492CrossRefPubMed Anderson M, Matthews KB, Stuart J (1978) Coagulation and fibrinolytic activity of cerebrospinal fluid. J Clin Pathol 31:488–492CrossRefPubMed
2.
go back to reference Brydon HL, Hayward R, Harknes W, Bayston R (1996) Does the cerebrospinal fluid protein concentration increase the risk of shunt complications? Br J Neurosurg 10(3):267–273CrossRefPubMed Brydon HL, Hayward R, Harknes W, Bayston R (1996) Does the cerebrospinal fluid protein concentration increase the risk of shunt complications? Br J Neurosurg 10(3):267–273CrossRefPubMed
3.
go back to reference Brydon HL, Keir G, Thompson EJ, Bayston R, Hayward R, Harkness W (1998) Protein adsorption to hydrocephalus shunt catheters: CSF protein adsorption. J Neurol Neurosurg Psychiatry 64:643–647CrossRefPubMed Brydon HL, Keir G, Thompson EJ, Bayston R, Hayward R, Harkness W (1998) Protein adsorption to hydrocephalus shunt catheters: CSF protein adsorption. J Neurol Neurosurg Psychiatry 64:643–647CrossRefPubMed
4.
go back to reference Deeken JF, Löscher W (2007) The blood–brain barrier and cancer: transporters, treatment, and Trojan horses. Clin Cancer Res 13:1663–1674CrossRefPubMed Deeken JF, Löscher W (2007) The blood–brain barrier and cancer: transporters, treatment, and Trojan horses. Clin Cancer Res 13:1663–1674CrossRefPubMed
5.
go back to reference Hanley DF, Williams MA, Naff NJ (1999) Intracranial hemorhage: time for an intervention. Crit Care Med 27:477–478CrossRefPubMed Hanley DF, Williams MA, Naff NJ (1999) Intracranial hemorhage: time for an intervention. Crit Care Med 27:477–478CrossRefPubMed
6.
go back to reference LaPointe M, Haines S (2002) Fibrinolytic therapy for intraventricular hemorrhage in adults. Cochrane Database of Systematic Reviews. Issue 3. Art.No.:CD003692. doi:10.1002/14651858.CD003692 LaPointe M, Haines S (2002) Fibrinolytic therapy for intraventricular hemorrhage in adults. Cochrane Database of Systematic Reviews. Issue 3. Art.No.:CD003692. doi:10.​1002/​14651858.​CD003692
7.
go back to reference Naff NJ, Hanley DF, Keyl PM, Tuhrim S, Kraut M, Bederson J, Bullock R, Mayer SA, Schmutzard E (2004) Intraventricular thrombolysis speeds blood clot resolution: results of a pilot, prospective, randomized, double-blind, controlled trial. Neurosurgery 54:577–584CrossRefPubMed Naff NJ, Hanley DF, Keyl PM, Tuhrim S, Kraut M, Bederson J, Bullock R, Mayer SA, Schmutzard E (2004) Intraventricular thrombolysis speeds blood clot resolution: results of a pilot, prospective, randomized, double-blind, controlled trial. Neurosurgery 54:577–584CrossRefPubMed
8.
go back to reference Occhipinti E, Carapella CM (1982) Shunt failure in hydrocephalus with high protein fluid. Monogr Neural Sci 8:220–222 Occhipinti E, Carapella CM (1982) Shunt failure in hydrocephalus with high protein fluid. Monogr Neural Sci 8:220–222
9.
go back to reference Ohnishi T, Sher PB, Posner JB et al (1990) Capillary permeability factor secreted by malignant brain tumor. Role in peritumoral brain edema and possible mechanism for anti-edema effect of glucocorticoids. J Neurosurg 72:245–251CrossRefPubMed Ohnishi T, Sher PB, Posner JB et al (1990) Capillary permeability factor secreted by malignant brain tumor. Role in peritumoral brain edema and possible mechanism for anti-edema effect of glucocorticoids. J Neurosurg 72:245–251CrossRefPubMed
10.
go back to reference Salmon JH (1977) A ventriculoperitoneal shunt for hemorrhagic or high protein fluid. Surg Neurol 8:60–70 Salmon JH (1977) A ventriculoperitoneal shunt for hemorrhagic or high protein fluid. Surg Neurol 8:60–70
11.
go back to reference Scarf JE (1963) Treatment of hydrocephalus: an historical and critical review of methods and results. J Neurol Neurosurg Psychiatry 26:1–26CrossRef Scarf JE (1963) Treatment of hydrocephalus: an historical and critical review of methods and results. J Neurol Neurosurg Psychiatry 26:1–26CrossRef
12.
go back to reference Shen PH, Matsuoka Y, Kawajiri K, Kanai M, Hoda K, Yamamoto S, Nishimura S (1990) Treatment of intraventricular hemorrhage using urokinase. Neurol Med Chir 30:329–333CrossRef Shen PH, Matsuoka Y, Kawajiri K, Kanai M, Hoda K, Yamamoto S, Nishimura S (1990) Treatment of intraventricular hemorrhage using urokinase. Neurol Med Chir 30:329–333CrossRef
13.
go back to reference Shuper A, Horev G, Michovitz S, Korenreich L, Zaizov R, Cohen IJ (1997) Optic chiasm glioma, electrolyte abnormalities, nonobstructive hydrocephalus and ascites. Med Ped Oncol 29:33–35CrossRef Shuper A, Horev G, Michovitz S, Korenreich L, Zaizov R, Cohen IJ (1997) Optic chiasm glioma, electrolyte abnormalities, nonobstructive hydrocephalus and ascites. Med Ped Oncol 29:33–35CrossRef
14.
go back to reference West A, Berger MS, Geyer R (1994) Childhood optic pathway tumors associated with ascites following ventriculoperitoneal shunt placement. Pediatr Neurosurg 21:254–259CrossRefPubMed West A, Berger MS, Geyer R (1994) Childhood optic pathway tumors associated with ascites following ventriculoperitoneal shunt placement. Pediatr Neurosurg 21:254–259CrossRefPubMed
15.
go back to reference Whitelaw A, Mowinckel MC, Abildgaard U (1995) Low levels of plasminogen in cerebrospinal fluid after intraventricular haemorrhage: a limiting factor for clot lysis? Acta Paediatrica 84(8):933–936CrossRefPubMed Whitelaw A, Mowinckel MC, Abildgaard U (1995) Low levels of plasminogen in cerebrospinal fluid after intraventricular haemorrhage: a limiting factor for clot lysis? Acta Paediatrica 84(8):933–936CrossRefPubMed
Metadata
Title
Use of intrathecal urokinase in repeated shunt and external ventricular drain blockage from high CSF protein due to an optic pathway glioma
Authors
David Shooman
Girish V. Vajramani
Jennifer Davidson
Owen C. Sparrow
Publication date
01-05-2010
Publisher
Springer-Verlag
Published in
Child's Nervous System / Issue 5/2010
Print ISSN: 0256-7040
Electronic ISSN: 1433-0350
DOI
https://doi.org/10.1007/s00381-009-1064-7

Other articles of this Issue 5/2010

Child's Nervous System 5/2010 Go to the issue